Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nikasa Pharmed is a leading Iranian pharmaceutical company focused on the development, manufacturing, and distribution of high-tech specialized medicines. The company operates as a knowledge-based entity, specializing in therapeutic areas such as oncology, hematology, cardiovascular diseases, and neurology. Nikasa Pharmed is recognized for its extensive portfolio of generic and branded-generic medications, including advanced tyrosine kinase inhibitors and anticoagulants. With a state-of-the-art manufacturing facility, the company aims to improve patient access to critical therapies within the Middle Eastern market. Their business model integrates local production with strategic partnerships to address unmet medical needs in complex disease states.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nikasa Pharmed.